Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Currently submitted to: JMIR Cancer

Date Submitted: Jul 14, 2026

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Multimodal ePRO Implementation Across Systemic Therapy and Radiotherapy: Real-World Use of Specified Symptom Items and Free-Text Reporting

  • Ian Kudel; 
  • Annette Christianson; 
  • Paula Pennanen; 
  • Mari Lahelma; 
  • Zoya Shamsi; 
  • Sushil Beriwal; 
  • Heather Curry; 
  • Maarit Bärlund

ABSTRACT

Background:

Electronic patient-reported outcomes are increasingly used in oncology care, but real-world multimodal implementation across systemic therapy and radiotherapy remains less well characterized.

Objective:

This study investigates enterprise-wide reporting within a cloud-based ePRO system among patients receiving systemic therapy (ST), radiation therapy (RT), or combined treatment (ST+RT), using a platform that integrates logic-based, treatment-specific questionnaires that include specified symptoms and free-text options.

Methods:

This retrospective, descriptive analysis included 1,445 patients who submitted at least one symptom report via ePRO between 2015 and 2021. Patients were stratified by cancer type (breast, prostate, other) and treatment modality (ST, RT, ST+RT). Questionnaires were administered based on expected treatment-related symptom onset; symptoms could also be reported ad hoc.

Results:

A total of 37,968 symptoms were reported: 83.5% via specified symptom items and 16.5% via standalone free-text reporting. Patients receiving ST+RT reported the highest volume. Breast cancer patients submitted 26,948 symptoms (71.0%), prostate cancer patients 1,246 (3.3%), and other cancers 9,774 (25.7%). Fatigue was the most frequently reported symptom. Free-text reporting was most common among breast cancer patients (81.1%), although all groups used this feature. Nearly three quarters (74.5%) of free-text entries duplicated symptoms already listed in modules, most frequently pain.

Conclusions:

These findings demonstrate the feasibility of a unified, flexible, treatment-specific ePRO platform across treatment modalities, with symptom patterns aligning with prior literature. The higher-than-expected use of free-text reporting suggests that some patients value a hybrid approach combining structured symptom capture with patient-driven narrative input, thus representing a practical and adaptable model for capturing treatment-related symptoms within routine oncology care.


 Citation

Please cite as:

Kudel I, Christianson A, Pennanen P, Lahelma M, Shamsi Z, Beriwal S, Curry H, Bärlund M

Multimodal ePRO Implementation Across Systemic Therapy and Radiotherapy: Real-World Use of Specified Symptom Items and Free-Text Reporting

JMIR Preprints. 14/07/2026:107048

DOI: 10.2196/preprints.107048

URL: https://preprints.jmir.org/preprint/107048

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.